Category: Dangerous Drugs

Is There Anyone Out There Testing Prescription Drugs BEFORE They Hurt People?

Drug manufacturer B. Braun Medical Inc. was forced to recall the blood thinning drug Heparin this week after reports surfaced that the Chinese import may be contaminated. This is the second manufacturing company in the past two months to recall the widely used blood thinner. Manufacturer Baxter International temporarily recalled the drug last month after patients complained of severe allergic reactions, including difficulty breathing and extreme drops in blood pressure, which can lead to “life threatening shock’. Four people have also died after the administration of Heparin, although the relationship between the drug and the contaminated vials has yet to be determined.

While Heparin is generally made of pig intestines and animal tissue, the recalled products were found to contain oversulfated chondroitin sulfate, a man made chemical that is not normally found in the drug’s chemistry. I find it also very coincidental that these contaminated drugs were imported from China-the same country that has recently brought us toxic toys and contaminated dog food. What’s more disturbing is that financial reports show that Chinese companies who manufacturer the drug have experienced a 13.7 % sales increase this year alone, thus earning a whopping $57.8 million in the first half of 2007.

With profits such as those mentioned above, I would venture to say that the Chinese manufacturers will not be cleaning up their act any time soon. Unfortunately, this seems to be a growing trend with pharmaceutical giants and drug manufacturers. It’s easier to sell the drug first, make an insane amount of money and then apologize later when people start to die or get sick. It appears that no amount of bad PR or medical malpractice suits will scare these companies into operating any differently. They will simply pay for the damages and create another drug for the doctors to release on the unsuspecting public. After all, our doctors have our best interest at heart when they prescribe these drugs…right? I’m not so convinced.

Free Legal Advice: Medical Malpractice

Merck Engaging In Consumer Fraud? Lead Investigator Accusing Company of Hiding Info About Inffective Drug Zetia

This past July, the leading drug investigator hired by Merck, Dr. John J.P. Kasteline accused pharmaceutical company of deliberately delaying the release of a drug trial in order to “hide something.” Although, the company was aware nearly two (2) years ago that its leading cholesterol drug, Zetia, showed no improvement over other drugs, Merck delayed publishing these results for nearly two (2) years. During that time, Merck continued to reap billions of dollars in profits from the drug that had been proven ineffective.

The investigator, Dr. Kasteline, was privately furious with Merck for the repeated delays and even threatened to resign. Not surprisingly, Merck has denied any wrong doing. Attempts by the New York Times to reach Dr. Kasteline have been unsuccessful.

Merck is the same pharmaceutical company that brought Vioxx to the market. Vioxx was later the subject of a class action law suit when Merck revealed that its own studies showed that the pain killer doubled the risk of heart attacks. After several jury trials found the company liable (and awarded substantial damages) the company agreed to compensate people whose heart attacks were linked to the drug. Pharmaceutical and drug injury lawyers are watching this latest revelation very carefully.

If it can be shown that Merck has engaged in deceptive and fraudulent practices, it may very well be the target or additional lawsuits under the New Jersey Consumer Fraud Act and other common law fraud claims.

Free Legal Advice: Medical Malpractice

Prescription drug Singular linked to suicide and behavioral changes

Pharmaceutical giant, Merck, has come under investigation yet again- this time concerning the asthma and allegory drug Singular. The Federal Drug Administration (FDA) announced on March 27th that it will be working with Merck to determine if there is link between Merck’s asthma and allergy drug, Singular, and suicide. Singular is marketed as a drug used to treat asthma and the symptoms associated with allergies such as sneezing, runny nose and itching of nose. The drug is also known to be used to prevent exercise induced asthma.

The FDA was moved to begin the investigation after receiving numerous reports of mood and behavior changes, suicidal thinking and actual cases of suicide that were reported in several patients who took the drug.

Located in Whitehouse, New Jersey, Merck is the same the pharmaceutical company who brought the drug Vioxx to the public. Vioxx was removed from shelves after the company admitted that the medication was linked to heart attacks and strokes in thousands of people. This past summer, Merck agreed to pay 4.8 billion in settlements for patients who had documented injuries linked to the drug.

Ironically, this settlement seemed to be a bargain to Merck as Vioxx accounted for 2.5 billion of Merck’s 2003 profits and many billions of dollars over the life of the drug. Merck was forced to pull the Vioxx off the market in 2004 after its own studies showed that the pain killer doubled the risk of heart attack when taken for at least 18 months.

Similarly, the drug Singular, has accounted for 4.3 billion dollars of Merck’s sales last year. The FDA has asked the company to do a deeper analysis into its data and disclose any possible links to suicide. Merck’s officials have agreed to cooperate in the investigation.

In the meantime, patients that are currently using Singular should monitor and document any unfavorable side effects associated with its usage. In addition, if you are a patient currently experiencing suicidal thoughts or behavioral changes, contact your doctor immediately to discuss alternative treatment options.

Free Legal Advice: Medical Malpractice